Results 141 to 150 of about 13,559 (225)

The effect of medroxyprogesterone acetate plus conjugated equine estrogens on lipoprotein(a) and apolipoprotein concentrations in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Diabetol Metab Syndr
Han R, Wang Z, Prabahar K, Wan D.
europepmc   +1 more source

Cumulative Live Birth Rates in Women Undergoing Progestin-Primed Ovarian Stimulation Using Medroxyprogesterone Acetate, Dydrogesterone, and Progesterone: A Retrospective Analysis. [PDF]

Drug Des Devel Ther
Wu F, Lin J, Zhang J, Wang X, Huang J, Lin J.   +5 more
europepmc   +1 more source

Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. [PDF]

J Gynecol Oncol
Kitazawa S, Sakai K, Kawaida M, Chiyoda T, Nishio H, Banno K, Susumu N, Yamagami W.   +7 more
europepmc   +1 more source

The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials. [PDF]

Diabetol Metab Syndr
Zhou F, Prabahar K, Shu J.
europepmc   +1 more source

Cardiometabolic Risk Marker Changes in Centrally Obese Women Using Depot Medroxyprogesterone Acetate (DMPA) in Kigali, Rwanda. [PDF]

Rwanda J Med Health Sci
Kantarama E, Uwizeye D, Uwineza A.
europepmc   +1 more source

Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data. [PDF]

Front Pharmacol
Su L, Xu R, Ren Y, Zhao S, Liu W, Du Z.
europepmc   +1 more source

Polyphyllin VII enhances the sensitivity of endometrial carcinoma cells to medroxyprogesterone acetate through upregulating miR‑33a‑5p expression. [PDF]

Oncol Lett
Liu H, Peng Y, Zhuang X.
europepmc   +1 more source

Depot medroxyprogesterone acetate concentrations in patients with and without the use of antiseizure medications. [PDF]

Contraception
Dutton C, Mody SK, Nippita S, Dodge LE, Pang T, Pennell PB, Davis A.   +6 more
europepmc   +1 more source

Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial. [PDF]

Reprod Health
Guo H, Du T, Gao H, Xi Q, Wu L, Lyu Q, Zhu Q.   +6 more
europepmc   +1 more source

Serum concentrations of medroxyprogesterone acetate were undetectable on OPU+5 days and had no effect on the serum progesterone level in patients undergoing the progestin-primed ovarian stimulation protocol. [PDF]

Front Endocrinol (Lausanne)
Chen X, Yan X, Xu H, Hu Y, Jiang S, Wang X, Peng H, Feng B, Zhang C, Diao H, Zhang Y.   +10 more
europepmc   +1 more source